Aging population and future burden of pneumococcal pneumonia in the United States.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 22448012.
- Also identified by DOI 10.1093/infdis/jis240.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pneumococcal pneumonia is concentrated among the elderly. Using a decision analytic model, we projected the future incidence of pneumococcal pneumonia and associated healthcare utilization and costs accounting for an aging US population. Between 2004 and 2040, as the population increases by 38%, pneumococcal pneumonia hospitalizations will increase by 96% (from 401 000 to 790 000), because population growth is fastest in older age groups experiencing the highest rates of pneumococcal disease. Absent intervention, the total cost of pneumococcal pneumonia will increase by $2.5 billion annually, and the demand for healthcare services for pneumococcal pneumonia, especially inpatient capacity, will double in coming decades.
Medical subject headings
- Health Care Costs
- Health Services
- Hospitalization
- Pneumonia, Pneumococcal